196 related articles for article (PubMed ID: 19297024)
1. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.
An G; Miwa T; Song WL; Lawson JA; Rader DJ; Zhang Y; Song WC
Mol Immunol; 2009 May; 46(8-9):1702-9. PubMed ID: 19297024
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
[TBL] [Abstract][Full Text] [Related]
3. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
4. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
Bao L; Haas M; Minto AW; Quigg RJ
Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
[TBL] [Abstract][Full Text] [Related]
5. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
6. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.
Wu G; Hu W; Shahsafaei A; Song W; Dobarro M; Sukhova GK; Bronson RR; Shi GP; Rother RP; Halperin JA; Qin X
Circ Res; 2009 Feb; 104(4):550-8. PubMed ID: 19131645
[TBL] [Abstract][Full Text] [Related]
7. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice.
Li B; Xu YJ; Chu XM; Gao MH; Wang XH; Nie SM; Yang F; Lv CY
Immunol Lett; 2013; 156(1-2):68-81. PubMed ID: 24084445
[TBL] [Abstract][Full Text] [Related]
9. The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice.
Lewis RD; Jackson CL; Morgan BP; Hughes TR
Mol Immunol; 2010 Feb; 47(5):1098-105. PubMed ID: 19959238
[TBL] [Abstract][Full Text] [Related]
10. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
[TBL] [Abstract][Full Text] [Related]
12. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
[TBL] [Abstract][Full Text] [Related]
13. Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.
Lin F; Salant DJ; Meyerson H; Emancipator S; Morgan BP; Medof ME
J Immunol; 2004 Feb; 172(4):2636-42. PubMed ID: 14764738
[TBL] [Abstract][Full Text] [Related]
14. Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59.
Yun S; Leung VW; Botto M; Boyle JJ; Haskard DO
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1714-6. PubMed ID: 18617646
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
16. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates.
Chen RH; Naficy S; Logan JS; Diamond LE; Adams DH
Xenotransplantation; 1999 Aug; 6(3):194-200. PubMed ID: 10503786
[TBL] [Abstract][Full Text] [Related]
17. CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism.
Lewis RD; Perry MJ; Guschina IA; Jackson CL; Morgan BP; Hughes TR
Am J Pathol; 2011 Oct; 179(4):1601-7. PubMed ID: 21816131
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the development of vascular and renal lesions in mice with a simultaneous deficiency of
Marek I; Canu M; Cordasic N; Rauh M; Volkert G; Fahlbusch FB; Rascher W; Hilgers KF; Hartner A; Menendez-Castro C
Biol Sex Differ; 2017; 8():19. PubMed ID: 28572914
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
Hayashi S; Isobe K; Emi N; Yokoyama I; Okada H; Nakashima I; Takagi H
Eur Surg Res; 1996; 28(6):440-6. PubMed ID: 8954321
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between human DAF and CD59 in protecting cells from human complement-mediated lysis.
Xu L; Wu W; Zhao Z; Shao H; Liu W; Liu H; Li W
J Biochem Mol Biol; 2006 Nov; 39(6):743-8. PubMed ID: 17129411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
